Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Overweight women with PCOS are more likely to have excess male hormones.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

AR gene not major factor in female hair loss; different from male hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Combination therapy improves hair growth in advanced hair loss.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

A new method accurately measures nine specific hormones in human blood.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Acceptance reduces hair loss distress and medical consultations; coping mechanisms increase them.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.